Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 96T |
|---|---|
| Brand | ProteoGenix |
| Product type | Elisa assay kits |
| Product name | Anti-Rabies Virus (RV) Glycoprotein (G) Human IgM ELISA Kit |
|---|---|
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stocks, 3-5 weeks if production is needed |
| Storage condition | 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles |
| Brand | ProteoGenix |
| Note | For research use only. |
| Immunogen | Glycoprotein |
| Assay type | Quantitative |
| Detection method | Colorimetric |
| Recovery | 80-120% |
The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgM ELISA Kit is a highly sensitive and specific tool used for the detection and quantification of anti-RV G IgM antibodies in human serum or plasma samples. This kit is designed for research use and is not intended for diagnostic purposes.
RV G glycoprotein is a transmembrane protein that is present on the surface of the rabies virus. It is composed of a single polypeptide chain of approximately 500 amino acids and has a molecular weight of around 60 kDa. The protein is heavily glycosylated, with up to 30% of its molecular weight being attributed to carbohydrates.
RV G glycoprotein plays a crucial role in the pathogenesis of rabies virus infection. It is responsible for the attachment of the virus to host cells and the subsequent fusion of the viral envelope with the host cell membrane. This allows the virus to enter the host cell and initiate the infection process.
In addition to its role in viral entry, RV G glycoprotein also plays a crucial role in the induction of the host immune response. It is a major target for neutralizing antibodies and is responsible for the majority of the protective immunity against rabies virus.
Rabies virus is a highly lethal neurotropic virus that causes acute encephalitis in humans and animals. It is estimated that around 59,000 people die from rabies infection every year, with the majority of cases occurring in developing countries. Currently, there is no effective treatment for rabies once clinical symptoms appear, highlighting the need for effective preventive measures.
RV G glycoprotein has been identified as a potential therapeutic target for the development of novel antiviral drugs. By targeting this protein, it may be possible to prevent viral entry into host cells and inhibit the progression of the infection.
The Anti-Rabies Virus (RV) Glycoprotein (G) Human IgM ELISA Kit is a valuable tool for research use in the study of rabies virus infection. It can be used to detect and quantify anti-RV G IgM antibodies in human serum or plasma samples, providing valuable insights into the immune response to the virus.
– Studying the kinetics of the immune response to rabies virus infection – Evaluating the efficacy of rabies vaccines – Investigating the prevalence of rabies virus in different populations – Screening for potential therapeutic agents that target RV G glycoprotein
In conclusion, the Anti-Rabies Virus (RV) Glycoprotein (G) Human IgM ELISA Kit is a highly sensitive and specific tool for the detection and quantification of anti-RV G IgM antibodies in human serum or plasma samples. It plays a crucial role in the study of rabies virus infection and has the potential to be used as a therapeutic target for the development of novel antiviral drugs. Further research and development in this area may lead to improved treatments and preventive measures for this deadly virus.
Send us a message from the form below
Reviews
There are no reviews yet.